Reviewed by the PeptideMind Team · Updated July 18, 2026

Mito Prime Blend (NAD+, MOTS-c, 5-Amino-1MQ) Dosage Guide, Benefits & Side Effects

Mito Prime combines NAD+, MOTS-c, and 5-Amino-1MQ in a 10:1:1 ratio for research into cellular energy, mitochondrial function, and metabolic health.

As seen on

American PressStreet InsiderBusiness InsiderBenzingaCBSYahoo Finance

Mito Prime Blend (NAD+, MOTS-c, 5-Amino-1MQ) Dosage Guide for Fat Loss / Metabolic

This blend combines NAD+, MOTS-c, and 5-Amino-1MQ in a fixed 10:1:1 ratio to support cellular energy and metabolic research. The three components cannot be dosed independently once mixed.

Vial size

120 mg

Bacteriostatic water

3 mL

Dosing

10–12 mg

Frequency

Daily

Cycle

4–8 weeks

Benefit

Fat Loss / Metabolic

Explore calculators

What is Mito Prime Blend (NAD+, MOTS-c, 5-Amino-1MQ)?

Mito Prime is a three-component research blend that packs NAD+ (100 mg), MOTS-c (10 mg), and 5-Amino-1MQ (10 mg) into a single 120 mg lyophilized vial in a 10:1:1 ratio. This exact composition is independently confirmed across multiple research-chemical vendors, commonly sold at ~99% purity with HPLC/LC-MS COAs. Each ingredient targets cellular energy, metabolism, and the biology of aging from a different angle. Only MOTS-c is a true peptide; NAD+ is a coenzyme and 5-Amino-1MQ is a small-molecule NNMT inhibitor, though all three are commonly marketed together as a 'peptide blend.' No human or animal trial has tested this exact three-compound combination; the rationale and evidence below are inherited from the individual components, most of which is preclinical rodent data.

Metabolic

Research targets include glucose regulation, insulin sensitivity, and energy metabolism.

Longevity

Research targets include cellular aging, senescence, and long-term healthspan.

Weight

Research targets include appetite regulation, fat metabolism, and body composition.

METABOLIC

Mito Prime

Longevity

Is Mito Prime Blend (NAD+, MOTS-c, 5-Amino-1MQ) FDA approved?

Mito Prime Blend (NAD+, MOTS-c, 5-Amino-1MQ) is not an FDA-approved drug. It is intended for research purposes only and is not approved for human consumption, diagnostic, or therapeutic use.

Research Use Only

Mito Prime Blend (NAD+, MOTS-c, 5-Amino-1MQ) has not been evaluated by the FDA for safety or efficacy in humans.

No Clinical Oversight

Not manufactured under FDA-regulated quality or clinical standards.

Unregulated Sourcing

Purity, dosing, and sourcing are not verified through FDA testing or oversight.

A smartphone screen displaying FDA status for a drug, indicating "FDA approved drug: No" and "Classification: Research use only." A banner notes "Research Only" with the disclaimer "not for human use," emphasizing its intended use for laboratory and analytical purposes.

Our top-rated vendor

View all vendors

Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing — no paid placements, no affiliate influence. We update this list as new data comes in.

Based on current scores, this vendor ranks highest across those criteria.

Protide Health logo

Protide Health

#1 Rated Research Peptide Supplier

How to reconstitute Mito Prime Blend (NAD+, MOTS-c, 5-Amino-1MQ)

View guide

The materials you'll need and step-by-step instructions for safely mixing Mito Prime Blend (NAD+, MOTS-c, 5-Amino-1MQ) with bacteriostatic water.

Materials needed

Your Mito Prime Blend (NAD+, MOTS-c, 5-Amino-1MQ) vial (lyophilized)

Alcohol swabs

Bacteriostatic sterile water

3 mL syringes (Luer Lock tip)

25G or 27G needles (Luer Lock). Other gauges may also be acceptable.

Sharps container (optional)

1

Remove the caps

Remove the caps from both your Mito Prime Blend (NAD+, MOTS-c, 5-Amino-1MQ) vial and your bacteriostatic water vial.
2

Sanitize the rubber stoppers

Wipe down the rubber stoppers on both vials with alcohol swabs and let them dry for about 3 minutes.
3

Attach the needle

Take your 3 mL syringe and needle. Twist the needle's plastic hub into the Luer Lock tip on the syringe to secure it.
4

Draw the bac water

Pull back on the plunger to draw your desired volume of bacteriostatic water. If you overfill, just push the excess back in until you reach the right marker on the syringe.

How much bac water? Mito Prime Blend (NAD+, MOTS-c, 5-Amino-1MQ) typically comes in a 120 mg vial. We recommend 3 mL of bacteriostatic water, though anywhere between 1 mL and 3 mL is acceptable. For larger vials you can use up to 5 mL — more bac water makes microdosing easier, but insulin needles usually max out at 1 mL per injection. That means a lot of bac water might force you into multiple injections to hit your target dose. Unless you're microdosing, 2 mL per vial is a solid rule of thumb.
5

Insert the needle into the Mito Prime Blend (NAD+, MOTS-c, 5-Amino-1MQ) vial

With the bac water in your syringe, insert the needle into the Mito Prime Blend (NAD+, MOTS-c, 5-Amino-1MQ) vial at a slight angle to avoid pressure buildup.

Use a thin needle: Stick to 25G or higher to avoid damaging the rubber stopper. Higher gauge means a thinner needle.
6

Release the water gently

Let the water run gently down the side of the vial. Don't inject it forcefully.

Heads up: Sometimes the plunger pushes itself in as soon as the needle enters the vial. Hold the plunger back so you have full control over how fast the bac water enters.
7

Swirl to dissolve

Avoid shaking. Gently swirl, flip, and roll the vial to dissolve the powder.

Be patient: This usually takes 2 to 5 minutes of consistent swirling, mixing in a circular motion, and gently flipping the vial up and down. The water needs to run through the powder many times to fully dissolve it. Don't shake or get aggressive with it.
8

Check for full dissolution

The solution should be clear with no visible particles. If it's cloudy or clumpy, wait a minute and repeat the swirling step.
9

Cap, dispose, and store

Once you're done, cap the needle and dispose of it (ideally in a sharps container). Store the reconstituted Mito Prime Blend (NAD+, MOTS-c, 5-Amino-1MQ) vial in the fridge whenever it's not in use. It will stay good for approximately 30 days.

How to Store Mito Prime Blend (NAD+, MOTS-c, 5-Amino-1MQ)

Mito Prime ships as a lyophilized (freeze-dried) powder. Store the unreconstituted vial refrigerated or frozen and protected from light until ready to reconstitute, following standard peptide/coenzyme handling. Once reconstituted with bacteriostatic water, keep refrigerated at 2-8°C; vendor guidance for this specific blend indicates use within roughly 4-6 weeks, and any solution that becomes discolored or cloudy should be discarded.

Keep lyophilized powder cold and dark

Store the unreconstituted 120 mg vial refrigerated or frozen, away from direct light, until ready to reconstitute.

Refrigerate after reconstitution

Once mixed with bacteriostatic water, store at 2-8°C and use within approximately 4-6 weeks, per vendor guidance for this blend.

Discard if appearance changes

Do not use reconstituted solution that becomes cloudy, discolored, or shows visible particulate.

A smartphone displaying a "Storage Guide" for peptides, indicating a safe storage temperature range of 2–8°C, with warnings to keep away from light, heat, and freezing. The background is light blue, and additional tips on protecting the peptides are visible below the temperature range.

What Are the Benefits of Mito Prime Blend (NAD+, MOTS-c, 5-Amino-1MQ)?

What research says it may help with, and how it works in the body.

fat loss

5-Amino-1MQ (~7% body weight, ~35% fat mass reduction over 11 days at 20mg/kg TID SC; Neelakantan et al. 2018) and MOTS-c (obesity prevention over 5 weeks at 15mg/kg/day IP; Lee et al. 2015) both reduced fat mass in diet-induced-obese mice through NAD+-linked and AMPK-linked mechanisms. Human confirmation is missing for both.

energy and metabolism

NAD+ is required for ATP production, and topping up a declining pool is the mechanistic rationale for this blend (Covarrubias et al. 2020/21); a controlled human infusion study confirmed plasma NAD+ rises with infusion but did not measure subjective energy outcomes.

metabolic health

MOTS-c activated AMPK and improved insulin sensitivity in diet-induced obese mice by week 4 of daily dosing, and reduced age-related insulin resistance in older animals (Lee et al. 2015, Cell Metabolism).

longevity

The most speculative indication, resting on NAD+ decline as a driver of aging (Covarrubias et al. 2020/21) and on MOTS-c improving physical performance and healthspan markers in aged mice, including animals started late in life (Reynolds et al. 2021, Nature Communications). No human longevity outcome exists for any of these compounds alone or blended.

What Are the Side Effects of Mito Prime Blend (NAD+, MOTS-c, 5-Amino-1MQ)?

Who should avoid it, warning signs to watch for, and what to know before combining it with other compounds.

Who Should Avoid It

Avoid if pregnant, nursing, or managing a hormone-sensitive condition

Known hypersensitivity to NAD+, MOTS-c, or 5-Amino-1MQ

Active cardiovascular disease (per-component NAD+ infusion data includes cardiac symptoms)

Not established for use in minors

Stop Right Away If You Notice

Severe flushing, chest tightness, or difficulty breathing during or after dosing

Persistent or severe gastrointestinal upset, vomiting, or dehydration

Signs of allergic reaction: rash, hives, swelling, or difficulty breathing

Spreading redness, warmth, or discharge at the injection site

Unusual heart palpitations or chest pain

Persistent severe headache or dizziness

Milder Signs to Watch For

Discolored, clumped, or cloudy solution after reconstitutionUnusual or strong chemical odor from the reconstituted solutionVisible particulate matter after reconstitutionSticky, discolored, or heat-damaged lyophilized powder
Was it helpful?Yes
No

How Long Should a Mito Prime Blend (NAD+, MOTS-c, 5-Amino-1MQ) Cycle Last?

This breaks down how long a typical Mito Prime Blend (NAD+, MOTS-c, 5-Amino-1MQ) cycle runs and what research suggests happens at each stage. Research shows that staying on a peptide continuously, without a break, may make it less effective over time.

That's why most research protocols build in a break between cycles, often called a washout period, to let the body reset before starting again.

Day 1-3
Acute AMPK activation and transient plasma NAD+ rise. Reasoned estimate combining MOTS-c's rapid AMPK-phosphorylation window (Lee et al. 2015, Cell Metabolism) with NAD+ infusion pharmacokinetics showing plasma peaks within hours of dosing.
Week 1-2
Early fat-mass reduction and exercise-capacity gains observed in rodents: ~7% body weight and ~35% fat-mass loss after 11 days of 5-Amino-1MQ dosing in obese mice (Neelakantan et al. 2018); doubled running capacity after 2 weeks of daily MOTS-c dosing in aged mice (Reynolds et al. 2021).
Week 4-5
Peak insulin-sensitization and metabolic homeostasis effects, based on the MOTS-c diet-induced-obesity mouse study, which showed insulin-sensitivity gains by week 4 and sustained improvement through 5 weeks of daily dosing (Lee et al. 2015).
Month 2-4
Reasoned estimate, not blend-specific: sustained cellular-energy/NAD+ pathway effects with continued dosing, extrapolated from chronic nicotinamide riboside rodent studies run 9-18 weeks, which showed dose-dependent and inconsistent metabolic benefit rather than a clear peak.
Post-Discontinuation
Reasoned estimate: plasma/tissue NAD+ elevation and AMPK signaling likely return toward baseline within 1-2 weeks of stopping, based on NAD+ pharmacokinetics showing rapid reversal within 24-48 hours after single-dose infusion. No direct discontinuation/washout data exists for MOTS-c or 5-Amino-1MQ.

Mito Prime Blend (NAD+, MOTS-c, 5-Amino-1MQ) Research References

It is a preclinical compound

6Research references

Mito Prime Blend (NAD+, MOTS-c, 5-Amino-1MQ)

Mito Prime Blend (NAD+, MOTS-c, 5-Amino-1MQ) is a preclinical compound

NAD+ metabolism and its roles in cellular processes during ageing

Covarrubias AJ, Perrone R, Grozio A, Verdin E. Nature Reviews Molecular Cell Biology, Vol 22, pp. 119-141 (published online 22 Dec 2020; print issue 2021). Describes a gradual drop in tissue and cellular NAD+ across aging in rodents and humans, linked to metabolic disease, cognitive decline, and sarcopenia. PMID 33353981.

2021

The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance

Lee C, Zeng J, Drew BG, et al. Cell Metabolism 21(3):443-454. Original paper showing MOTS-c activates AMPK, improves insulin sensitivity in diet-induced obese mice (15mg/kg/day IP over 5 weeks), and reduces age-related insulin resistance in older animals.

2015

MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis

Reynolds JC, Bwiza CP, Lee C, et al. Nature Communications 12:470. Showed MOTS-c is induced by exercise (~11.9-fold rise in skeletal muscle) and that treating mice, including those started late in life (22 months), boosted running capacity and physical performance across young, middle-aged, and old groups.

2021

Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity

Kraus D, Yang Q, Kong D, et al. Nature 508:258-262. Antisense-oligonucleotide knockdown of NNMT in fat and liver protected mice against diet-induced obesity, glucose intolerance, and fatty liver, partly by shifting adipose NAD+ and SAM levels. This paper established NNMT as a target; it did not test the small-molecule 5-Amino-1MQ itself.

2014

Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice

Neelakantan H, Vance V, Wetzel MD, et al. Biochemical Pharmacology 147:141-152. This is the paper that actually tested 5-Amino-1MQ: diet-induced-obese mice given 5-Amino-1MQ (20mg/kg TID SC for 11 days) showed ~7% body-weight loss and ~35% fat-mass reduction without changed food intake.

2018

Development & validation of LC-MS/MS assay for 5-amino-1-methyl quinolinium in rat plasma: application to pharmacokinetic and oral bioavailability studies

Awosemo O, Neelakantan H, Watowich S, et al. Journal of Pharmaceutical and Biomedical Analysis. Reported rat half-life of ~3.8h (IV) / ~6.9h (oral) and ~38.4% oral bioavailability for 5-Amino-1MQ. No human PK data exists for this compound.

2021

Frequently Asked Questions About Mito Prime Blend (NAD+, MOTS-c, 5-Amino-1MQ)

Straight answers on reconstitution, dosing, and safety, everything you need to research with confidence. For research reference only.